Molecular imaging in drug discovery and development.

Imaging in the era of molecular oncology. Nature (2008) 11.10

Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol (2007) 3.54

In vivo molecular photoacoustic tomography of melanomas targeted by bioconjugated gold nanocages. ACS Nano (2010) 2.29

Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions. J Infect Dis (2011) 1.96

Molecular imaging with optics: primer and case for near-infrared fluorescence techniques in personalized medicine. J Biomed Opt (2008) 1.94

Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer. Clin Cancer Res (2008) 1.66

In vivo imaging of molecularly targeted phage. Neoplasia (2006) 1.59

Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging. Acta Radiol (2009) 1.49

Molecular imaging and therapy of cancer with radiolabeled nanoparticles. Nano Today (2009) 1.47

Screening phage display libraries for organ-specific vascular immunotargeting in vivo. Proc Natl Acad Sci U S A (2005) 1.46

Barrier capacity of human placenta for nanosized materials. Environ Health Perspect (2009) 1.41

Imaging biomarkers predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer. Clin Cancer Res (2009) 1.35

Phage display in molecular imaging and diagnosis of cancer. Chem Rev (2010) 1.34

Quantitative imaging of disease signatures through radioactive decay signal conversion. Nat Med (2013) 1.33

Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine. Nanoscale Res Lett (2012) 1.31

A practical guide to the construction of radiometallated bioconjugates for positron emission tomography. Dalton Trans (2011) 1.28

Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine. Clin Cancer Res (2008) 1.23

Multimodality molecular imaging of CD105 (Endoglin) expression. Int J Clin Exp Med (2010) 1.16

Activatable molecular systems using homologous near-infrared fluorescent probes for monitoring enzyme activities in vitro, in cellulo, and in vivo. Mol Pharm (2009) 1.13

The impact of quantitative imaging in medicine and surgery: Charting our course for the future. Quant Imaging Med Surg (2011) 1.13

Construction and validation of nano gold tripods for molecular imaging of living subjects. J Am Chem Soc (2014) 1.10

Development of molecular imaging in the European radiological community. Eur Radiol (2009) 1.08

Human breast cancer tumor models: molecular imaging of drug susceptibility and dosing during HER2/neu-targeted therapy. Radiology (2008) 1.08

A fluorescent, paramagnetic and PEGylated gold/silica nanoparticle for MRI, CT and fluorescence imaging. Contrast Media Mol Imaging (2010) 1.07

High-throughput sensing and noninvasive imaging of protein nuclear transport by using reconstitution of split Renilla luciferase. Proc Natl Acad Sci U S A (2004) 1.05

Multispectral fluorescence ultramicroscopy: three-dimensional visualization and automatic quantification of tumor morphology, drug penetration, and antiangiogenic treatment response. Neoplasia (2014) 1.03

Multifunctional Magnetic Nanoparticles for Medical Imaging Applications. J Mater Chem (2009) 1.03

Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents. Int J Nanomedicine (2015) 1.02

Monitoring the biodegradation of dendritic near-infrared nanoprobes by in vivo fluorescence imaging. Mol Pharm (2009) 1.00

A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects. Bioconjug Chem (2010) 1.00

A three-dimensional finite element model and image reconstruction algorithm for time-domain fluorescence imaging in highly scattering media. Phys Med Biol (2011) 0.99

Integrated nanosensors to determine levels and functional activity of human telomerase. Neoplasia (2008) 0.98

Multimodal imaging and treatment of bone metastasis. Clin Exp Metastasis (2008) 0.97

Live imaging of neural structure and function by fibred fluorescence microscopy. EMBO Rep (2006) 0.96

Molecular imaging with nucleic acid aptamers. Curr Med Chem (2011) 0.96

Polymer platforms for drug delivery and biomedical imaging. J Control Release (2007) 0.96

Molecular Imaging with Single-Walled Carbon Nanotubes. Nano Today (2009) 0.95

Imaging biomarkers as surrogate endpoints for drug development. Eur J Nucl Med Mol Imaging (2006) 0.94

The NIAID Integrated Research Facility at Frederick, Maryland: a unique international resource to facilitate medical countermeasure development for BSL-4 pathogens. Pathog Dis (2014) 0.93

Optical molecular imaging and its emerging role in colorectal cancer. Am J Physiol Gastrointest Liver Physiol (2010) 0.92

In vivo imaging of GLP-1R with a targeted bimodal PET/fluorescence imaging agent. Bioconjug Chem (2014) 0.92

Quantitative in vivo immunohistochemistry of epidermal growth factor receptor using a receptor concentration imaging approach. Cancer Res (2014) 0.91

Computed tomography-guided time-domain diffuse fluorescence tomography in small animals for localization of cancer biomarkers. J Vis Exp (2012) 0.91

Imaging readouts as biomarkers or surrogate parameters for the assessment of therapeutic interventions. Eur Radiol (2007) 0.90

Molecular imaging of atherosclerosis: clinical state-of-the-art. Heart (2013) 0.90

High-throughput optical screening of cellular mechanotransduction. Nat Photonics (2014) 0.90

Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: recent advances. Mater Today (Kidlington) (2016) 0.90

In vivo tomographic imaging with fluorescence and MRI using tumor-targeted dual-labeled nanoparticles. Int J Nanomedicine (2013) 0.90

Single-photon emission computed tomography in neurotherapeutics. NeuroRx (2005) 0.87

[18F]FLT-PET to predict pharmacodynamic and clinical response to cetuximab therapy in Ménétrier's disease. Ann Nucl Med (2012) 0.87

The evolution of imaging in cancer: current state and future challenges. Semin Oncol (2011) 0.87

Quantitative imaging biomarker ontology (QIBO) for knowledge representation of biomedical imaging biomarkers. J Digit Imaging (2013) 0.86

An optical probe for noninvasive molecular imaging of orthotopic brain tumors overexpressing epidermal growth factor receptor. Mol Cancer Ther (2012) 0.86

Quantitative mass spectrometry imaging of emtricitabine in cervical tissue model using infrared matrix-assisted laser desorption electrospray ionization. Anal Bioanal Chem (2014) 0.85

Optical fluorescent imaging to monitor temporal effects of microbubble-mediated ultrasound therapy. IEEE Trans Ultrason Ferroelectr Freq Control (2013) 0.85

Targeted signal-amplifying enzymes enhance MRI of EGFR expression in an orthotopic model of human glioma. Cancer Res (2011) 0.85

Single cell analysis of drug distribution by intravital imaging. PLoS One (2013) 0.85

Ultrasound-modulated fluorescence based on fluorescent microbubbles. J Biomed Opt (2014) 0.85

Intracellular dynamics of topoisomerase I inhibitor, CPT-11, by slit-scanning confocal Raman microscopy. Histochem Cell Biol (2009) 0.84

SPLASSH: Open source software for camera-based high-speed, multispectral in-vivo optical image acquisition. Biomed Opt Express (2010) 0.84

Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen. Biomark Insights (2008) 0.84

MRI in ocular drug delivery. NMR Biomed (2008) 0.84

Positron emission tomography imaging of tumor angiogenesis and monitoring of antiangiogenic efficacy using the novel tetrameric peptide probe 64Cu-cyclam-RAFT-c(-RGDfK-)4. Angiogenesis (2012) 0.84

Synergistic enhancement of iron oxide nanoparticle and gadolinium for dual-contrast MRI. Biochem Biophys Res Commun (2012) 0.83

Optical properties and application of a reactive and bioreducible thiol-containing tetramethylrhodamine dimer. Bioconjug Chem (2009) 0.83

USNCTAM perspectives on mechanics in medicine. J R Soc Interface (2014) 0.83

Structural optimization of Zn(II)-activated magnetic resonance imaging probes. Inorg Chem (2013) 0.83

Medical imaging in new drug clinical development. J Thorac Dis (2010) 0.82

EATRIS, a European initiative to boost translational biomedical research. Am J Nucl Med Mol Imaging (2013) 0.82

Propargyl 4-[F]fluorobenzoate: A Putatively More Stable Prosthetic group for the Fluorine-18 Labeling of Biomolecules via Click Chemistry. Curr Radiopharm (2009) 0.82

Multiscale observation of biological interactions of nanocarriers: from nano to macro. Microsc Res Tech (2010) 0.82

Determination of [11C]rifampin pharmacokinetics within Mycobacterium tuberculosis-infected mice by using dynamic positron emission tomography bioimaging. Antimicrob Agents Chemother (2015) 0.82

Imaging of angiogenesis. Angiogenesis (2010) 0.82

Synthesis of [F]Xenon Difluoride as a Radiolabeling Reagent from [F]Fluoride Ion in a Micro-reactor and at Production Scale. J Fluor Chem (2010) 0.82

Profiling distinct mechanisms of tumour invasion for drug discovery: imaging adhesion, signalling and matrix turnover. Clin Exp Metastasis (2008) 0.82

Can molecular imaging enable personalized diagnostics? An example using magnetomotive photoacoustic imaging. Ann Biomed Eng (2013) 0.82

A multimeric MR-optical contrast agent for multimodal imaging. Chem Commun (Camb) (2014) 0.81

Impact of treatment response metrics on photodynamic therapy planning and outcomes in a three-dimensional model of ovarian cancer. J Biomed Opt (2013) 0.81

Indocyanine green-loaded perfluorocarbon nanoemulsions for bimodal (19)F-magnetic resonance/nearinfrared fluorescence imaging and subsequent phototherapy. Quant Imaging Med Surg (2013) 0.80

Accelerated image reconstruction in fluorescence molecular tomography using dimension reduction. Biomed Opt Express (2012) 0.80

MicroSPECT and MicroPET Imaging of Small Animals for Drug Development. Toxicol Res (2013) 0.80

Design of Protease Activated Optical Contrast Agents That Exploit a Latent Lysosomotropic Effect for Use in Fluorescence-Guided Surgery. ACS Chem Biol (2015) 0.79

Targeted Cancer Therapy with Tumor Necrosis Factor-Alpha. Biochem Insights (2008) 0.79

Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling. Biomark Insights (2007) 0.78

ENaC-mediated effects assessed by MRI in a rat model of hypertonic saline-induced lung hydration. Br J Pharmacol (2010) 0.78

Development of hypoxia enhanced 111In-labeled Bombesin conjugates: design, synthesis, and in vitro evaluation in PC-3 human prostate cancer. Bioconjug Chem (2012) 0.78

Evaluation of a triple-helical peptide with quenched FluorSophores for optical imaging of MMP-2 and MMP-9 proteolytic activity. Molecules (2014) 0.78

Real-time monitoring of protein conformational changes using a nano-mechanical sensor. PLoS One (2014) 0.78

Influence of C-Trap Ion Accumulation Time on the Detectability of Analytes in IR-MALDESI MSI. Anal Chem (2015) 0.78

Targeted delivery of gold nanoparticle contrast agents for reporting gene detection by magnetic resonance imaging. Chem Commun (Camb) (2015) 0.78

Ocular pharmacokinetic study using T₁ mapping and Gd-chelate- labeled polymers. Pharm Res (2011) 0.77

Pre-clinical evaluation of tyrosine kinase inhibitors for treatment of acute leukemia. J Vis Exp (2013) 0.77

Endoscopic molecular imaging: status and future perspective. Clin Endosc (2013) 0.77

Side-by-Side Comparison of Commonly Used Biomolecules That Differ in Size and Affinity on Tumor Uptake and Internalization. PLoS One (2015) 0.77

Nanoparticle-facilitated functional and molecular imaging for the early detection of cancer. Front Mol Biosci (2014) 0.77

In vivo quantification of mouse autoimmune arthritis by PET/CT. Int J Rheum Dis (2014) 0.77

Layer-resolved colorectal tissues using nonlinear microscopy. Lasers Med Sci (2015) 0.76

Visualization of mitotic arrest of cell cycle with bioluminescence imaging in living animals. Mol Imaging Biol (2013) 0.76

Rational design of matrix metalloproteinase-13 activatable probes for enhanced specificity. ACS Chem Biol (2013) 0.76

Copper-64 Radiopharmaceuticals for Oncologic Imaging. PET Clin (2009) 0.76

Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nat Med (2008) 14.47

Restoration of p53 function leads to tumour regression in vivo. Nature (2007) 12.62

The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med (2007) 11.51

Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (2009) 10.47

Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol (2005) 9.57

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med (2003) 9.09

Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest (2007) 8.65

Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell (2012) 7.36

Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol (2002) 6.06

Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther (2005) 6.04

Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc Natl Acad Sci U S A (2006) 5.90

Fluorescence molecular tomography resolves protease activity in vivo. Nat Med (2002) 5.53

The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies. Cancer Cell (2006) 5.34

Arthritis critically dependent on innate immune system players. Immunity (2002) 5.31

Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell (2002) 5.11

The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell (2010) 5.11

Myocardial infarction accelerates atherosclerosis. Nature (2012) 4.48

Chip-NMR biosensor for detection and molecular analysis of cells. Nat Med (2008) 4.29

Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation (2007) 4.20

Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med (2013) 4.14

Magnetic relaxation switches capable of sensing molecular interactions. Nat Biotechnol (2002) 4.13

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci U S A (2004) 4.12

Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med (2012) 4.11

A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med (2007) 3.96

Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol (2011) 3.95

Tetrazine-based cycloadditions: application to pretargeted live cell imaging. Bioconjug Chem (2008) 3.93

Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity (2006) 3.92

Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation (2007) 3.85

Fast and sensitive pretargeted labeling of cancer cells through a tetrazine/trans-cyclooctene cycloaddition. Angew Chem Int Ed Engl (2009) 3.63

Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation (2006) 3.57

Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation (2007) 3.51

Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc Natl Acad Sci U S A (2006) 3.38

Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev (2008) 3.34

A secreted luciferase for ex vivo monitoring of in vivo processes. Nat Methods (2008) 3.31

Intravital imaging. Cell (2011) 3.18

Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med (2012) 2.92

Multivalent effects of RGD peptides obtained by nanoparticle display. J Med Chem (2006) 2.91

MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res (2007) 2.90

Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J Am Coll Cardiol (2010) 2.90

Near-infrared fluorescence: application to in vivo molecular imaging. Curr Opin Chem Biol (2009) 2.89

An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater (2006) 2.84

Ultrasensitive clinical enumeration of rare cells ex vivo using a micro-hall detector. Sci Transl Med (2012) 2.82

The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell (2012) 2.78

Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct. Circ Res (2007) 2.77

Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc Natl Acad Sci U S A (2004) 2.77

Rapid detection and profiling of cancer cells in fine-needle aspirates. Proc Natl Acad Sci U S A (2009) 2.75

Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses. Proc Natl Acad Sci U S A (2006) 2.72

Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res (2005) 2.67

Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice. Gastroenterology (2002) 2.64

In vivo imaging of proteolytic activity in atherosclerosis. Circulation (2002) 2.62

Molecular imaging in the clinical arena. JAMA (2005) 2.59

A submillimeter resolution fluorescence molecular imaging system for small animal imaging. Med Phys (2003) 2.58

Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery. J Neurosurg (2006) 2.58

miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell (2008) 2.57

Bioorthogonal turn-on probes for imaging small molecules inside living cells. Angew Chem Int Ed Engl (2010) 2.57

Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation (2006) 2.56

A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res (2003) 2.55

Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation (2008) 2.52

Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection. Nat Nanotechnol (2010) 2.49

One-Pot Synthesis of New Symmetric and Asymmetric Xanthene Dyes. Tetrahedron Lett (2007) 2.49

Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci U S A (2009) 2.47

Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy. J Natl Cancer Inst (2007) 2.46

Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction. Circulation (2005) 2.45

Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjug Chem (2002) 2.45

Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation (2011) 2.45

Origins of tumor-associated macrophages and neutrophils. Proc Natl Acad Sci U S A (2012) 2.42

PET/MRI of inflammation in myocardial infarction. J Am Coll Cardiol (2012) 2.39

Identification of the target self-antigens in reperfusion injury. J Exp Med (2006) 2.38

Molecular imaging of cardiovascular disease. Circulation (2007) 2.33

Colonic adenocarcinomas: near-infrared microcatheter imaging of smart probes for early detection--study in mice. Radiology (2007) 2.29

PepBank--a database of peptides based on sequence text mining and public peptide data sources. BMC Bioinformatics (2007) 2.27

Quantitative real-time catheter-based fluorescence molecular imaging in mice. Radiology (2007) 2.26

Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor. Circulation (2007) 2.20

Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo. Circulation (2007) 2.19

18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. JACC Cardiovasc Imaging (2009) 2.17

Hybrid PET-optical imaging using targeted probes. Proc Natl Acad Sci U S A (2010) 2.17

Volumetric tomography of fluorescent proteins through small animals in vivo. Proc Natl Acad Sci U S A (2005) 2.16

Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors. Arterioscler Thromb Vasc Biol (2009) 2.15

Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat Immunol (2006) 2.12

In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res (2003) 2.12

Early window of diabetes determinism in NOD mice, dependent on the complement receptor CRIg, identified by noninvasive imaging. Nat Immunol (2012) 2.11

Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis. Proc Natl Acad Sci U S A (2009) 2.11

Biomedical applications of tetrazine cycloadditions. Acc Chem Res (2011) 2.10

Innate response activator B cells protect against microbial sepsis. Science (2012) 2.07

Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation (2009) 2.07

Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma. PLoS Med (2008) 2.06

Perturbational profiling of nanomaterial biologic activity. Proc Natl Acad Sci U S A (2008) 2.04

Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn Reson Med (2005) 2.03

Near-infrared optical imaging of proteases in cancer. Mol Cancer Ther (2003) 2.02

Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci U S A (2007) 2.02

Catheter-based in vivo imaging of enzyme activity and gene expression: feasibility study in mice. Radiology (2004) 2.01

WNT5A/JNK and FGF/MAPK pathways regulate the cellular events shaping the vertebrate limb bud. Curr Biol (2010) 2.00

Early photon tomography allows fluorescence detection of lung carcinomas and disease progression in mice in vivo. Proc Natl Acad Sci U S A (2008) 2.00

Analysis of mitosis and antimitotic drug responses in tumors by in vivo microscopy and single-cell pharmacodynamics. Cancer Res (2011) 1.99

The progress and promise of molecular imaging probes in oncologic drug development. Clin Cancer Res (2005) 1.97

Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury. Circulation (2008) 1.97

Micro-NMR for rapid molecular analysis of human tumor samples. Sci Transl Med (2011) 1.96

Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Invest (2010) 1.93

Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Acc Chem Res (2011) 1.93

Targeted delivery of multifunctional magnetic nanoparticles. Nanomedicine (Lond) (2007) 1.92